Inventor

ANGERBAUER ROLF

DE50 patents

Patents

50 patents

US5177080AJan 5, 1993

Substituted pyridyl-dihydroxy-heptenoic acid and its salts

BAYER AG401 citations99

US5006530AApr 9, 1991

Certain 7-[2,6-diisopropyl-4-phenyl-5-lower alkoxymethyl-pyrid-3-yl]-3,5-dihydroxy-6-enoates and derivatives useful for treating circulatory diseases

BAYER AG279 citations99

US5932587AAug 3, 1999

Heterocyclic-fused pyridines

BAYER AG77 citations96

US5925645AJul 20, 1999

2-aryl-substituted pyridines

BAYER AG51 citations96

US5169857ADec 8, 1992

7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis

BAYER AG62 citations96

US5120782AJun 9, 1992

Substituted pyrrolo-pyridines pharmaceuticals

BAYER AG59 citations96

US5032602AJul 16, 1991

Inhibiting HMG-CoA reductase with novel substituted 2-pyridones and pyrid-2-thiones

BAYER AG64 citations96

US5401746AMar 28, 1995

Substituted pyridines heptenoic acid derivatives, useful for treating arterioscleros, lipopotaemia and the like

BAYER AG26 citations93

US6207671B1Mar 27, 2001

Process for preparing sodium 3R,5S-(+)-erythro-(E)-7- 4-(4-fluorophenyl)-2,6-diisopropyl-5-methoxymethyl-pyrid-3-yl!-3,5-dihydroxy-hept-6-enoate

BAYER AG43 citations90

US6121330ASep 19, 2000

5-Hydroxyalkyl substituted phenyls and their use in medicaments for the treatment of arteriosclerosis and hyperlipoproteinaemia

BAYER AG12 citations74

US5470982ANov 28, 1995

Disubstituted pyridines

BAYER AG5 citations74

US5164506ANov 17, 1992

Substituted 2-pyridones and pyrid-2-thiones compounds

BAYER AG9 citations74

US5145959ASep 8, 1992

Substituted pyrido (2,3-d) pyrimidines as intermediates

BAYER AG9 citations74

US5137881AAug 11, 1992

Substituted pyrido-oxazine inhibitors of hmg-coa reductase

BAYER AG9 citations74

US5075311ADec 24, 1991

Hmg-coa reductase inhibiting substituted pryido (2,3-d) pyrimidines

BAYER AG12 citations74

US5034399AJul 23, 1991

Substituted 1,8-naphthyridines and their use in medicaments

BAYER AG15 citations74

US5032590AJul 16, 1991

Substituted hydroxylamines

BAYER AG10 citations74

US4988711AJan 29, 1991

HMG-CoA reductare-inhibiting N-substituted N-amino-pyrroles

BAYER AG8 citations74

US4968681ANov 6, 1990

Substituted hydroxylamines

BAYER AG8 citations74

US4757065AJul 12, 1988

Cephalosporins

BAYER AG6 citations74

US4754031AJun 28, 1988

Preparation of cephalosporins

BAYER AG11 citations74

US6277833B1Aug 21, 2001

Substituted triols

BAYER AG13 citations73

US5145857ASep 8, 1992

Hmg-coa reductase-inhibiting substituted amino-pyridines

BAYER AG3 citations63

US5064841ANov 12, 1991

HMG-COA reductase-inhibiting imino-substituted pyridines

BAYER AG2 citations63

US4992462AFeb 12, 1991

Substituted pyrroles

BAYER AG6 citations63

US4943568AJul 24, 1990

Cephalosporins

BAYER AG2 citations63

US4937255AJun 26, 1990

Disubstituted pyrroles

BAYER AG3 citations63

US4880795ANov 14, 1989

Cephalosporins

BAYER AG3 citations63

US4709023ANov 24, 1987

Process for the preparation of 7-amino-3-(3-formamidopyridinium)methyl-3-cephem-4-carboxylate, and its use for the synthesis of β-lactam antibiotics

BAYER AG2 citations63

US4686216AAug 11, 1987

7-[2-(2-aminothiazol-4-yl)-2-oximino-acetamido-3-quaternary-ammonium-methyl-3-cephem-4-carboxylates

BAYER AG4 citations63

US4632918ADec 30, 1986

Novel β-lactam antibiotics

BAYER AG6 citations63

US4626535ADec 2, 1986

Cephalosporins

BAYER AG2 citations62

US4968689ANov 6, 1990

Certain 2,6-diisopropyl-4-(4-fluoro-phenyl)-3,5-bis-dimethyl-3',5'-dihydroxy-hept-6-enoate-pyridine derivatives useful for treating lipoproteinaemia and arteriosclerosis

BAYER AG4 citations61

US5849749ADec 15, 1998

6-(hydroxymethyl-ethyl)pyridines

BAYER AG5 citations60

US5409910AApr 25, 1995

Substituted pyridines

BAYER AG3 citations60

US5138090AAug 11, 1992

Substituted biphenyls

BAYER AG2 citations60

US5502057AMar 26, 1996

Polysubstituted pyridines useful for treating lipoproteinanaemia and arteriosclerosis

BAYER AG0 citations52

US5183897AFeb 2, 1993

Certain intermediate imino-substituted pyridines

BAYER AG1 citations52

US5173495ADec 22, 1992

7-[(2,6-dialkyl-4-furyl or thienyl-pyridyl)]-3,5-di-(dihydroxy-6-enoates) useful for treating circulatory diseases

BAYER AG0 citations52

US4973598ANov 27, 1990

Substituted imidazolinones and imidazolinethiones

BAYER AG1 citations52

US4767754AAug 30, 1988

Cephalosporins

BAYER AG1 citations52

US4755597AJul 5, 1988

7-amino-3-(3-formamidopyridinium)methyl-3-cephem-4-carboxylate

BAYER AG0 citations52

US4988685AJan 29, 1991

Cephalosporins derivatives

BAYER AG1 citations51

ANGERBAUER ROLF

Patents

Substituted pyridyl-dihydroxy-heptenoic acid and its salts

Certain 7-[2,6-diisopropyl-4-phenyl-5-lower alkoxymethyl-pyrid-3-yl]-3,5-dihydroxy-6-enoates and derivatives useful for treating circulatory diseases

Heterocyclic-fused pyridines

2-aryl-substituted pyridines

7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis

Substituted pyrrolo-pyridines pharmaceuticals

Inhibiting HMG-CoA reductase with novel substituted 2-pyridones and pyrid-2-thiones

Substituted pyridines heptenoic acid derivatives, useful for treating arterioscleros, lipopotaemia and the like

Cycloalkano-pyridines

2-aryl-substituted pyridines

Cycloalkano-pyridines

Bicyclic-fused pyridines

Substituted triols

4-(Quinolin-2-yl-methoxy)-phenyl-acetic acid derivatives

Substituted 4-phenyl-pyridones and 4-phenyl-3-alkoxypyridines

Process for preparing sodium 3R,5S-(+)-erythro-(E)-7- 4-(4-fluorophenyl)-2,6-diisopropyl-5-methoxymethyl-pyrid-3-yl!-3,5-dihydroxy-hept-6-enoate

5-Hydroxyalkyl substituted phenyls and their use in medicaments for the treatment of arteriosclerosis and hyperlipoproteinaemia

Disubstituted pyridines

Substituted 2-pyridones and pyrid-2-thiones compounds

Substituted pyrido (2,3-d) pyrimidines as intermediates

Substituted pyrido-oxazine inhibitors of hmg-coa reductase

Hmg-coa reductase inhibiting substituted pryido (2,3-d) pyrimidines

Substituted 1,8-naphthyridines and their use in medicaments

Substituted hydroxylamines

HMG-CoA reductare-inhibiting N-substituted N-amino-pyrroles

Substituted hydroxylamines

Cephalosporins

Preparation of cephalosporins

Substituted triols

Hmg-coa reductase-inhibiting substituted amino-pyridines

HMG-COA reductase-inhibiting imino-substituted pyridines

Substituted pyrroles

Cephalosporins

Disubstituted pyrroles

Cephalosporins

Process for the preparation of 7-amino-3-(3-formamidopyridinium)methyl-3-cephem-4-carboxylate, and its use for the synthesis of β-lactam antibiotics

7-[2-(2-aminothiazol-4-yl)-2-oximino-acetamido-3-quaternary-ammonium-methyl-3-cephem-4-carboxylates

Novel β-lactam antibiotics

Cephalosporins

Certain 2,6-diisopropyl-4-(4-fluoro-phenyl)-3,5-bis-dimethyl-3&#39;,5&#39;-dihydroxy-hept-6-enoate-pyridine derivatives useful for treating lipoproteinaemia and arteriosclerosis

6-(hydroxymethyl-ethyl)pyridines

Substituted pyridines

Substituted biphenyls

Polysubstituted pyridines useful for treating lipoproteinanaemia and arteriosclerosis

Certain intermediate imino-substituted pyridines

7-[(2,6-dialkyl-4-furyl or thienyl-pyridyl)]-3,5-di-(dihydroxy-6-enoates) useful for treating circulatory diseases

Substituted imidazolinones and imidazolinethiones

Cephalosporins

7-amino-3-(3-formamidopyridinium)methyl-3-cephem-4-carboxylate

Cephalosporins derivatives

Certain 2,6-diisopropyl-4-(4-fluoro-phenyl)-3,5-bis-dimethyl-3',5'-dihydroxy-hept-6-enoate-pyridine derivatives useful for treating lipoproteinaemia and arteriosclerosis